ACS Guideline Adherence Lowers Women's Cancer Risk

Share this content:
ACS Guideline Adherence Lowers Women's Cancer Risk
ACS Guideline Adherence Lowers Women's Cancer Risk

(HealthDay News) -- All-cause and cancer-specific mortality is lower in postmenopausal women who follow the American Cancer Society (ACS) Nutrition and Physical Activity Cancer Prevention Guidelines, according to research published in the January issue of Cancer Prevention Research.

Cynthia A. Thomson, MD, of the University of Arizona in Tucson, and colleagues analyzed data for 65,838 postmenopausal women enrolled in the Women's Health Initiative Observational Study. The researchers sought to assess how the ACS cancer prevention guidelines for healthy eating, physical activity, and avoiding or limiting alcohol intake, affect risk of cancer and mortality.

The researchers found that, at a median follow-up of 12.6 years, postmenopausal women with the highest scores, compared with those with the lowest scores, for ACS guidelines had a 17% lower risk of any cancer, 22% lower risk of breast cancer, and 52% lower risk of colorectal cancer.

Following the ACS guidelines was associated with a 20% lower risk of cancer-specific mortality and a 27% lower risk of all-cause mortality for postmenopausal women with the highest scores compared with those with the lowest scores.

"Behaviors concordant with Nutrition and Physical Activity Cancer Prevention Guidelines were associated with lower risk of total, breast, and colorectal cancers and lower cancer-specific mortality in postmenopausal women," the researchers wrote.

References

  1. Thompson CA, McCullough ML, Wertheim BC, et al. Nutrition and Physical Activity Cancer Prevention Guidelines, Cancer Risk, and Mortality in the Women's Health Initiative. Cancer Prev Res. 2014;doi:10.1158/1940-6207.CAPR-13-0258.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs